NEXE Innovations 2024 Corporate Update: A Year of Strategic Progress - Setting the Stage for Sustainable Growth
NEXE Innovations Inc. ("NEXE" or the "Company") (TSXV: NEXE) (Frankfurt: NX5) (OTC: NEXNF), a compostable and innovative ...
Ensysce Biosciences Issues Annual Shareholder Letter
FDA Breakthrough Therapy designation received for PF614-MPAR ~~ PF614-MPAR second clinical trial initiated ~~ Lead clinical candidate identified for OUD program ~~ PF614 Phase 3 trial poised to ...